97 related articles for article (PubMed ID: 29441960)
1. Carbamazepine 10,11-epoxidation in human liver microsomes: influence of the
Miyata-Nozaka Y; Zain SM; Taguchi M; Shigeyama M; Isobe T; Hanioka N
Pharmazie; 2017 Dec; 72(12):747-750. PubMed ID: 29441960
[TBL] [Abstract][Full Text] [Related]
2. Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation.
Kerr BM; Thummel KE; Wurden CJ; Klein SM; Kroetz DL; Gonzalez FJ; Levy RH
Biochem Pharmacol; 1994 Jun; 47(11):1969-79. PubMed ID: 8010982
[TBL] [Abstract][Full Text] [Related]
3. Prediction of in vivo carbamazepine 10,11-epoxidation from in vitro metabolic studies with human liver microsomes: importance of its sigmoidal kinetics.
Sakamoto M; Itoh T; Fujiwara R
Biol Pharm Bull; 2013; 36(12):1959-63. PubMed ID: 24292054
[TBL] [Abstract][Full Text] [Related]
4. Microsomal metabolism of carbamazepine and oxcarbazepine in liver and placenta.
Myllynen P; Pienimäki P; Raunio H; Vähäkangas K
Hum Exp Toxicol; 1998 Dec; 17(12):668-76. PubMed ID: 9988371
[TBL] [Abstract][Full Text] [Related]
5. CYP3A4 and CYP3A7-mediated carbamazepine 10,11-epoxidation are activated by differential endogenous steroids.
Nakamura H; Torimoto N; Ishii I; Ariyoshi N; Nakasa H; Ohmori S; Kitada M
Drug Metab Dispos; 2003 Apr; 31(4):432-8. PubMed ID: 12642469
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the impact of CYP3A polymorphisms on the formation of α-hydroxytamoxifen and N-desmethyltamoxifen in human liver microsomes.
Mugundu GM; Sallans L; Guo Y; Shaughnessy EA; Desai PB
Drug Metab Dispos; 2012 Feb; 40(2):389-96. PubMed ID: 22096084
[TBL] [Abstract][Full Text] [Related]
7. Effect of CYP3A5*3 genotype on serum carbamazepine concentrations at steady-state in Korean epileptic patients.
Park PW; Seo YH; Ahn JY; Kim KA; Park JY
J Clin Pharm Ther; 2009 Oct; 34(5):569-74. PubMed ID: 19744012
[TBL] [Abstract][Full Text] [Related]
8. Effect of CYP3A5 genotypes on the pharmacokinetics of carbamazepine when used as monotherapy or co-administered with phenytoin, phenobarbital or valproic acid in Thai patients.
Panomvana D; Traiyawong T; Towanabut S
J Pharm Pharm Sci; 2013; 16(4):502-10. PubMed ID: 24210059
[TBL] [Abstract][Full Text] [Related]
9. Carbamazepine: a 'blind' assessment of CVP-associated metabolism and interactions in human liver-derived in vitro systems.
Pelkonen O; Myllynen P; Taavitsainen P; Boobis AR; Watts P; Lake BG; Price RJ; Renwick AB; Gómez-Lechón MJ; Castell JV; Ingelman-Sundberg M; Hidestrand M; Guillouzo A; Corcos L; Goldfarb PS; Lewis DF
Xenobiotica; 2001 Jun; 31(6):321-43. PubMed ID: 11513246
[TBL] [Abstract][Full Text] [Related]
10. MD Investigation on the Interaction between Carbamazepine and Two CYP Isoforms, CYP3A4 and CYP3A5.
Liu S; Xu Y
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768510
[TBL] [Abstract][Full Text] [Related]
11. Effects of CYP3A5 and UGT2B7 variants on steady-state carbamazepine concentrations in Chinese epileptic patients.
Lu Q; Huang YT; Shu Y; Xu P; Xiang DX; Qu Q; Qu J
Medicine (Baltimore); 2018 Jul; 97(30):e11662. PubMed ID: 30045320
[TBL] [Abstract][Full Text] [Related]
12. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy.
Wang P; Yin T; Ma HY; Liu DQ; Sheng YH; Wang C; Zhou BT
Epilepsy Res; 2015 Nov; 117():52-7. PubMed ID: 26421491
[TBL] [Abstract][Full Text] [Related]
13. Sertraline-induced potentiation of the CYP3A4-dependent neurotoxicity of carbamazepine: an in vitro study.
Ghosh C; Hossain M; Spriggs A; Ghosh A; Grant GA; Marchi N; Perucca E; Janigro D
Epilepsia; 2015 Mar; 56(3):439-49. PubMed ID: 25656284
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of carbamazepine by CYP3A6: a model for in vitro drug interactions studies.
Mesdjian E; Sérée E; Charvet B; Mirrione A; Bourgarel-Rey V; Desobry A; Barra Y
Life Sci; 1999; 64(10):827-35. PubMed ID: 10096433
[TBL] [Abstract][Full Text] [Related]
15. Influence of cytochrome P450 3A5 (CYP3A5) genetic polymorphism on dose-adjusted plasma levels of carbamazepine in epileptic patients in South Indian population.
Ganesapandian M; Ramasamy K; Adithan S; Narayan SK
Indian J Pharmacol; 2019; 51(6):384-388. PubMed ID: 32029960
[TBL] [Abstract][Full Text] [Related]
16. Associations between CYP3A4, CYP3A5 and SCN1A polymorphisms and carbamazepine metabolism in epilepsy: A meta-analysis.
Zhao GX; Zhang Z; Cai WK; Shen ML; Wang P; He GH
Epilepsy Res; 2021 Jul; 173():106615. PubMed ID: 33756436
[TBL] [Abstract][Full Text] [Related]
17. Effects of EPHX1 and CYP3A4*22 genetic polymorphisms on carbamazepine metabolism and drug response among Tunisian epileptic patients.
Chbili C; Fathallah N; Laouani A; Nouira M; Hassine A; Ben Amor S; Ben Ammou S; Ben Salem C; Saguem S
J Neurogenet; 2016 Mar; 30(1):16-21. PubMed ID: 27276192
[TBL] [Abstract][Full Text] [Related]
18. Pathways of carbamazepine bioactivation in vitro. III. The role of human cytochrome P450 enzymes in the formation of 2,3-dihydroxycarbamazepine.
Pearce RE; Lu W; Wang Y; Uetrecht JP; Correia MA; Leeder JS
Drug Metab Dispos; 2008 Aug; 36(8):1637-49. PubMed ID: 18463198
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of carbamazepine and carbamazepine-10,11-epoxide on hepatic cytochromes P450 in the rat.
Panesar SK; Bandiera SM; Abbott FS
Drug Metab Dispos; 1996 Jun; 24(6):619-27. PubMed ID: 8781776
[TBL] [Abstract][Full Text] [Related]
20. The relative contributions of CYP3A4 and CYP3A5 to the metabolism of vinorelbine.
Topletz AR; Dennison JB; Barbuch RJ; Hadden CE; Hall SD; Renbarger JL
Drug Metab Dispos; 2013 Sep; 41(9):1651-61. PubMed ID: 23780963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
